Atrial Fibrillation Trial, Recruiting (NCT03428048)

Atrial Fibrillation Trial, Recruiting NCT03428048 Sponsor: Cardiovascular Innovation and Research Institute Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT03428048 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be over 18 years old.
You must be willing and able to understand the study details and sign a consent form agreeing to take part.
You must be available to attend follow-up appointments after joining the study.
You must have been diagnosed with either coronary artery disease (a condition affecting the blood vessels that supply the heart) or atrial fibrillation, also known as AFib (an irregular heartbeat condition).

Who may not be able to join:

You may not be able to join if you are unwilling, or for any reason unable, to sign the consent form agreeing to take part in the study.
You may not be able to join if the study team believes you may have difficulty attending or completing follow-up appointments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frank A Laws, MD, Valley View Hospital

Phone: 970-384-7433

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03428048

Sponsor: Cardiovascular Innovation and Research Institute

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 970-384-7433

More information: https://clinicaltrials.gov/study/NCT03428048

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be over 18 years old.
You must be willing and able to understand the study details and sign a consent form agreeing to take part.
You must be available to attend follow-up appointments after joining the study.
You must have been diagnosed with either coronary artery disease (a condition affecting the blood vessels that supply the heart) or atrial fibrillation, also known as AFib (an irregular heartbeat condition).

Who may not be able to join:

You may not be able to join if you are unwilling, or for any reason unable, to sign the consent form agreeing to take part in the study.
You may not be able to join if the study team believes you may have difficulty attending or completing follow-up appointments.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cardiovascular Innovation and Research Institute

Registry

ClinicalTrials.gov

Start date

1 March 2016

Est. completion

1 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change from baseline in Atrial Fibrillation Effect on Quality -of-Life (AFEQT) questionnaire at designated follow-up intervals; Change from baseline in Veterans Rand (VR) 12; Number of patients that experience a re-admit status post intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov